Lupin surges on inking distribution pact with Scope Ophthalmics
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Lupin is currently trading at Rs. 2193.05, up by 2.85 points or 0.13% from its previous closing of Rs. 2190.20 on the BSE.
The scrip opened at Rs. 2186.45 and has touched a high and low of Rs. 2207.65 and Rs. 2175.25 respectively. So far 9505 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2312.00 on 05-Sep-2024 and a 52 week low of Rs. 1113.00 on 31-Oct-2023.
Last one week high and low of the scrip stood at Rs. 2238.00 and Rs. 2160.60 respectively. The current market cap of the company is Rs. 100143.98 crore.
The promoters holding in the company stood at 46.98%, while Institutions and Non-Institutions held 46.10% and 6.92% respectively.
Lupin has inked a distribution pact with Ireland-based Scope Ophthalmics to market a product range, indicated for the treatment of various eye conditions, in Mexico. The company has signed a distribution agreement with Scope Ophthalmics for the registration and marketing of Moist Heat Mask, a Tea Tree Oil Eyelid Cleansing Gel and Tea Tree Oil Eyelid Wipes of the Optase range in Mexico. The products are used for eye conditions like dry eyes, blepharitis and meibomian gland dysfunction (MGD).
Through the signature of this collaboration with Lupin, Scope is expanding its footprint in Latin America.
Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
